A single dose PK/PD study was performed using the PI3K inhibitor GDC-0941 and the MEK inhibitor PD 0325901, as single agents and in combination, in HCT116 human tumour xenograft-bearing mice, over a time course of 0.25–24 hours. The gene discussed is PIK3CA; the disease is neoplasm.